Response to Letter Regarding Article, "Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial"

William N. Whiteley*, Douglas Thompson, Peter Sandercock

*Corresponding author for this work

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)E133-E133
Number of pages1
Issue number7
Publication statusPublished - Jul 2014

Keywords / Materials (for Non-textual outputs)

  • Female
  • Humans
  • Intracranial Hemorrhages
  • Male
  • Stroke
  • Tissue Plasminogen Activator

Cite this